Original Biomedicals Co (ROCO:6483) Shares Outstanding (EOP): 66.59 Mil (As of Dec. 2025)


ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
32 GF Score
Price NT$13.40
! 2 Warning Signs
View Full Analysis

What is Original Biomedicals Co Shares Outstanding (EOP)?

Original Biomedicals Co ROCO:6483 32 Shares Outstanding (EOP) is 66.59 Mil as of Dec. 2025. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Original Biomedicals Co's shares outstanding for the quarter that ended in Dec. 2025 was 66.59 Mil.

Original Biomedicals Co's quarterly shares outstanding increased from Jun. 2025 (66.35 Mil) to Dec. 2025 (66.59 Mil). It means Original Biomedicals Co issued new shares from Jun. 2025 to Dec. 2025 .

Original Biomedicals Co's annual shares outstanding increased from Dec. 2024 (65.99 Mil) to Dec. 2025 (66.59 Mil). It means Original Biomedicals Co issued new shares from Dec. 2024 to Dec. 2025 .


Original Biomedicals Co  (ROCO:6483) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Original Biomedicals Co Shares Outstanding (EOP) Related Terms


Original Biomedicals Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co Shares Outstanding (EOP) Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only 23.61 47.05 64.55 65.99 66.59

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.55 65.55 65.99 66.35 66.59

ROCO:6483 vs ZTS, UTHR: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Original Biomedicals Co Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Original Biomedicals Co's Shares Outstanding (EOP) falls into.


ROCO:6483
32GF Score
Original Biomedicals Co Ltd ROCO:6483
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 66.59 Mil mean?
Original Biomedicals Co (ROCO:6483) has a Shares Outstanding (EOP) of 66.59 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Original Biomedicals Co and its competitors.
Is Original Biomedicals Co's Shares Outstanding (EOP) too high?
Original Biomedicals Co's current Shares Outstanding (EOP) is 66.59 Mil. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Shares Outstanding (EOP) compare to ZTS and UTHR?
Original Biomedicals Co's Shares Outstanding (EOP) of 66.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Original Biomedicals Co and its competitors. Original Biomedicals Co's current Shares Outstanding (EOP) is 66.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Shares Outstanding (EOP) of 66.59 Mil. The current Shares Outstanding (EOP) is 66.59 Mil. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Shares Outstanding (EOP) is 66.59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score

Get the complete analysis for ROCO:6483

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.40
Price